BioMarin Pharmaceutical Inc. – Filings and Transcripts

NASDAQ: BMRN
Share price (9/29/26): $59.87
Market cap (9/29/26): $11.6 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Plenge Robert M

Plenge Robert M

Davis George Eric

Davis George Eric

Countouriotis Athena

News Filter

Material Definitive Agreement

Change in Directors, Officers or Compensation

Announces Global Settlement With Ascendis Pharma a/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC